In 2011, Moore et al. found a high specificity associated with a high sensitivity of serum HE4 in preoperatively distinguishing stage IA from stage IB, i.e., the invasion of less or more than 50% of the myometrium by the carcinoma in 96 women with carcinoma of the endometrium [47]. The gene discussed is WFDC2; the disease is carcinoma.